Aqr Capital Management LLC Fate Therapeutics Inc Transaction History

Aqr Capital Management LLC

  • $64.6 Billion
  • Q2 2024

A detailed history of Aqr Capital Management LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Aqr Capital Management LLC holds 16,460 shares of FATE stock, worth $58,762. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,460
Previous 22,098 25.51%
Holding current value
$58,762
Previous $162,000 67.28%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$3.26 - $7.08 $18,379 - $39,917
-5,638 Reduced 25.51%
16,460 $53,000
Q1 2024

May 15, 2024
SELL
$3.54 - $8.35 $753,878 - $1.78 Million
-212,960 Reduced 90.6%
22,098 $162,000
Q4 2023

Feb 14, 2024
SELL
$1.65 - $3.94 $161,457 - $385,540
-97,853 Reduced 29.39%
235,058 $879,000
Q3 2023

Nov 14, 2023
BUY
$2.02 - $5.04 $672,480 - $1.68 Million
332,911 New
332,911 $705,000
Q1 2023

May 15, 2023
BUY
$4.24 - $11.12 $1.15 Million - $3.02 Million
271,399 New
271,399 $1.55 Million
Q2 2022

Aug 15, 2022
SELL
$17.78 - $42.39 $274,487 - $654,416
-15,438 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$29.67 - $60.28 $338,030 - $686,770
-11,393 Reduced 42.46%
15,438 $599,000
Q4 2021

Feb 14, 2022
SELL
$47.84 - $64.34 $444,959 - $598,426
-9,301 Reduced 25.74%
26,831 $1.57 Million
Q3 2021

Nov 15, 2021
SELL
$59.27 - $95.73 $118,065 - $190,694
-1,992 Reduced 5.23%
36,132 $2.14 Million
Q2 2021

Aug 16, 2021
BUY
$67.25 - $92.52 $287,628 - $395,708
4,277 Added 12.64%
38,124 $3.31 Million
Q1 2021

May 17, 2021
SELL
$72.16 - $117.4 $106,436 - $173,165
-1,475 Reduced 4.18%
33,847 $2.79 Million
Q4 2020

Feb 16, 2021
SELL
$38.09 - $100.95 $197,458 - $523,324
-5,184 Reduced 12.8%
35,322 $3.21 Million
Q3 2020

Nov 16, 2020
SELL
$30.41 - $40.5 $273,051 - $363,649
-8,979 Reduced 18.14%
40,506 $1.62 Million
Q2 2020

Aug 17, 2020
SELL
$20.21 - $35.23 $60,508 - $105,478
-2,994 Reduced 5.71%
49,485 $1.7 Million
Q1 2020

May 15, 2020
BUY
$17.28 - $31.88 $577,031 - $1.06 Million
33,393 Added 174.96%
52,479 $1.17 Million
Q4 2019

Feb 14, 2020
SELL
$13.39 - $20.73 $140,501 - $217,519
-10,493 Reduced 35.47%
19,086 $374,000
Q3 2019

Nov 14, 2019
SELL
$15.47 - $22.5 $6,234 - $9,067
-403 Reduced 1.34%
29,579 $459,000
Q2 2019

Aug 14, 2019
SELL
$15.61 - $20.44 $59,161 - $77,467
-3,790 Reduced 11.22%
29,982 $609,000
Q1 2019

May 14, 2019
SELL
$13.15 - $18.71 $66,302 - $94,335
-5,042 Reduced 12.99%
33,772 $593,000
Q4 2018

Feb 14, 2019
SELL
$11.48 - $16.98 $96,351 - $142,513
-8,393 Reduced 17.78%
38,814 $498,000
Q2 2018

Aug 14, 2018
BUY
$9.16 - $13.48 $138,957 - $204,491
15,170 Added 47.35%
47,207 $535,000
Q1 2018

May 15, 2018
BUY
$6.3 - $13.77 $201,833 - $441,149
32,037 New
32,037 $313,000

Others Institutions Holding FATE

# of Institutions
190
Shares Held
123M
Call Options Held
15K
Put Options Held
14K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $346M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email